Urology Medical News about Rofecoxib; post-shock wave lithotripsy pain

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Evaluation and management of post-shock wave lithotripsy pain with third-generation lithotriptors using rofecoxib
International Braz J Urol, 06/23/09

Greene TD et al. - Pain after SWL is moderate to severe using third-generation lithotriptors and is significantly reduced by POD 3. Younger patients and those with significant pretreatment pain had more pain after treatment. Preemptive Rofecoxib reduced post-SWL pain, but had no impact on stone passage. This article contributes greatly to our understanding of pain with SWL. First, it quantifies the natural progression of pain after SWL - moderate-severe (5 or 10) for the first 2 days, subsiding almost completely by Day 7. Secondly, it identifies patients with a higher risk of significant pain post-operative - younger patients, and those with pre-SWL pain. These subsets would warrant further investigation in the future to identify effective adjuvant analgesic approaches.

<< Previous
Urinary bladder cancer: diffusion-weighted MR imaging--accuracy...

Next >>
Temperature safety profile of laparoscopic devices: Harmonic ACE...